Leidal, K. | Search bioRxiv

bioRxiv2024

Boltz-1: Democratizing Biomolecular Interaction Modeling

Understanding biomolecular interactions is fundamental to advancing fields like drug discovery and protein design. In this paper, we introduce BO_SCPLOWOLTZC_SCPLOW-1, an open-source deep learning model incorporating innovations in model architecture, speed optimization, and data processing achieving AO_SCPLOWLPHAC_SCPLOWFO_SCPLOWOLDC_SCPLOW3-level accuracy in predicting the 3D structures of biomolecular complexes. BO_SCPLOWOLTZC_SCPLOW-1 demonstrates a performance on-par with state-of-the-art commercial models on a range of diverse benchmarks, setting a new benchmark for commercially accessible tools in structural biology. Further, we push the boundary of capabilities of these models with BO_SCPLOWOLTZC_SCPLOWO_SCPCAP-C_SCPCAPO_SCPLOWSTEERINGC_SCPLOW, a new inference time steering technique that is able to fix hallucinations and non-physical predictions from the models. By releasing the training and inference code, model weights, datasets, and benchmarks under the MIT open license, we aim to foster global collaboration, accelerate discoveries, and provide a robust platform for advancing biomolecular modeling.

biophysics↗

bioRxiv2023

Cell-type-specific nuclear morphology predicts genomic instability and prognosis in multiple cancer types

While alterations in nucleus size, shape, and color are ubiquitous in cancer, comprehensive quantification of nuclear morphology across a whole-slide histologic image remains a challenge. Here, we describe the development of a pan-tissue, deep learning-based digital pathology pipeline for exhaustive nucleus detection, segmentation, and classification and the utility of this pipeline for nuclear morphologic biomarker discovery. Manually-collected nucleus annotations were used to train an object detection and segmentation model for identifying nuclei, which was deployed to segment nuclei in H&E-stained slides from the BRCA, LUAD, and PRAD TCGA cohorts. Interpretable features describing the shape, size, color, and texture of each nucleus were extracted from segmented nuclei and compared to measurements of genomic instability, gene expression, and prognosis. The nuclear segmentation and classification model trained herein performed comparably to previously reported models. Features extracted from the model revealed differences sufficient to distinguish between BRCA, LUAD, and PRAD. Furthermore, cancer cell nuclear area was associated with increased aneuploidy score and homologous recombination deficiency. In BRCA, increased fibroblast nuclear area was indicative of poor progression-free and overall survival and was associated with gene expression signatures related to extracellular matrix remodeling and anti-tumor immunity. Thus, we developed a powerful pan-tissue approach for nucleus segmentation and featurization, enabling the construction of predictive models and the identification of features linking nuclear morphology with clinically-relevant prognostic biomarkers across multiple cancer types.

cancer biology↗